Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

MKC

McCormick & Co., Inc.

May 03 • 04:00PM ET

75.45

Dollar change +0.31
Percentage change 0.41	%

Consumer Defensive • Packaged Foods • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO VO IVV NOBL VTV VOE RSP VIG VYM

Index	S&P 500	P/E	28.77	EPS (ttm)	2.62	Insider Own	6.39%	Shs Outstand	251.30M	Perf Week	-0.37%
Market Cap	20.25B	Forward P/E	24.56	EPS next Y	3.07	Insider Trans	-0.20%	Shs Float	251.26M	Perf Month	-1.26%
Income	707.50M	PEG	4.02	EPS next Q	0.60	Inst Own	81.55%	Short Float	1.84%	Perf Quarter	11.48%
Sales	6.70B	P/S	3.02	EPS this Y	6.20%	Inst Trans	1.62%	Short Ratio	2.35	Perf Half Y	17.69%
Book/sh	19.49	P/B	3.87	EPS next Y	7.15%	ROA	5.42%	Short Interest	4.63M	Perf Year	-14.18%
Cash/sh	0.66	P/C	113.77	EPS next 5Y	7.15%	ROE	14.01%	52W Range	59.13 - 94.39	Perf YTD	10.27%
Dividend Est.	1.68 (2.23%)	P/FCF	20.09	EPS past 5Y	-6.36%	ROI	8.26%	52W High	-20.07%	Beta	0.75
Dividend TTM	1.62 (2.15%)	Quick Ratio	0.30	Sales past 5Y	4.76%	Gross Margin	37.90%	52W Low	27.60%	ATR (14)	1.42
Dividend Ex-Date	Apr 05, 2024	Current Ratio	0.68	EPS Y/Y TTM	6.15%	Oper. Margin	15.45%	RSI (14)	57.32	Volatility	1.60% 1.68%
Employees	13800	Debt/Eq	0.85	Sales Y/Y TTM	4.78%	Profit Margin	10.56%	Recom	2.94	Target Price	76.78
Option/Short	Yes / Yes	LT Debt/Eq	0.64	EPS Q/Q	19.41%	Payout	61.84%	Rel Volume	0.80	Prev Close	75.14
Sales Surprise	3.44%	EPS Surprise	9.26%	Sales Q/Q	2.38%	Earnings	Mar 26 BMO	Avg Volume	1.97M	Price	75.45
SMA20	1.40%	SMA50	4.68%	SMA200	4.89%	Trades		Volume	1,584,330	Change	0.41%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-02-24	Upgrade	Argus	Hold → Buy
Feb-01-24	Initiated	Citigroup	Sell	$60
Jan-22-24	Downgrade	Consumer Edge Research	Overweight → Equal Weight
Sep-22-23	Initiated	HSBC Securities	Hold	$86
Sep-13-23	Initiated	TD Cowen	Market Perform	$87
Jun-06-23	Upgrade	BofA Securities	Underperform → Buy	$75 → $100
Apr-14-23	Resumed	Stifel	Hold	$82
Mar-10-23	Initiated	UBS	Sell	$71
Jan-27-23	Upgrade	Bernstein	Mkt Perform → Outperform	$90
Nov-15-22	Initiated	Exane BNP Paribas	Outperform	$94
Jul-06-22	Downgrade	Argus	Buy → Hold
Feb-17-22	Upgrade	Argus	Hold → Buy	$112
Jan-19-22	Downgrade	Credit Suisse	Outperform → Neutral	$100
Mar-17-21	Downgrade	Argus	Buy → Hold
Sep-24-20	Initiated	Argus	Buy	$215
Jun-22-20	Upgrade	Jefferies	Underperform → Hold	$167
May-14-20	Upgrade	Credit Suisse	Neutral → Outperform	$147 → $187
Mar-19-20	Downgrade	BofA/Merrill	Neutral → Underperform	$175 → $140
Jan-23-20	Initiated	Jefferies	Underperform
Jan-22-20	Initiated	Jefferies	Underperform

Show Previous Ratings

May-02-24 02:20PM	Cognizant Technology Solutions Corporation (NASDAQ:CTSH) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 03:32PM	How Hain Celestial's new CEO plans to take Terra chips, Sleepytime tea to the next level (Yahoo Finance)
02:48PM	Stock Market Crash Alert: 3 Must-Buy Consumer Stocks When Prices Plunge (InvestorPlace)
Apr-25-24 11:30AM	McCormick (MKC) Down 0.2% Since Last Earnings Report: Can It Rebound? (Zacks)
Apr-22-24 12:53PM	McCormick (MKC) Benefits From Strategic Buyouts & Cost Savings (Zacks)
03:19AM	Loading…
Apr-16-24 03:19AM	10 Best Beverage Dividend Stocks To Buy Now (Insider Monkey)
Apr-02-24 04:50PM	S&P 500 Gains and Losses Today: Health Care Stocks Move Lower (Investopedia)
08:00AM	Cognizant signs a large, global infrastructure agreement with McCormick & Company, Inc. (PR Newswire)
Mar-28-24 01:54PM	11 Best April Dividend Stocks To Invest In (Insider Monkey)
Mar-27-24 04:40PM	McCormick Declares $0.42 Quarterly Dividend (PR Newswire)
12:54PM	McCormick & Company, Incorporated (NYSE:MKC) Q1 2024 Earnings Call Transcript (Insider Monkey)
Mar-26-24 05:11PM	S&P 500 Gains and Losses Today: UPS Stock Tumbles Amid Near-Term Challenges (Investopedia) +10.52%
01:23PM	Top Stock Movers Now: McCormick, Seagate Technology, Tesla, and More (Investopedia)
12:50PM	Stocks to Watch Tuesday: Trump Media, GameStop, BuzzFeed, Tesla (The Wall Street Journal)
11:05AM	Heard on the Street: McCormick Stock Sees a Zesty Rally on Earnings Beat (The Wall Street Journal)
10:53AM	Loading…
10:53AM	MKC Stock Earnings: McCormick & Co Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:17AM	McCormick posts Q1 beat, net income rises 19% year over year (Yahoo Finance Video)
10:07AM	McCormick (MKC) Q1 Earnings & Sales Top Estimates, Grow Y/Y (Zacks)
09:32AM	McCormick Surges as Cost-Cutting, Higher Prices Fuel Earnings Beat (Investopedia)
07:03AM	McCormick Logs Higher 1Q Sales, Earnings (The Wall Street Journal)
06:30AM	McCORMICK REPORTS STRONG FIRST QUARTER PERFORMANCE AND REAFFIRMS 2024 OUTLOOK (PR Newswire)
Mar-25-24 05:11PM	TMTG, Case-Shiller Home Price Index: Tuesday's what to watch (Yahoo Finance Video)
Mar-24-24 10:58AM	What To Expect in the Markets This Week (Investopedia)
07:56AM	Inflation data, short trading week: What to watch this week (Yahoo Finance)
Mar-22-24 04:31PM	Fedspeak, PCE print, GameStop earnings: What to Watch Next Week (Yahoo Finance Video)
Mar-21-24 12:28PM	McCormick (MKC) Q1 Earnings Coming Up: Factors to Note (Zacks)
Mar-19-24 10:00AM	Analysts Estimate McCormick (MKC) to Report a Decline in Earnings: What to Look Out for (Zacks)
Mar-14-24 06:05AM	Omsom is taking Asian food mainstream as demand grows for ethnic packaged food (Yahoo Finance)
Feb-29-24 08:00AM	McCormick & Company to Report 2024 First Quarter Financial Results on March 26, 2024 (PR Newswire)
Feb-28-24 03:40PM	McCormick & Company Named to Barron's Most Sustainable U.S. Companies List (PR Newswire)
01:42PM	Loading…
Feb-23-24 01:42PM	Food companies detail 3 big trends in packaged goods right now (Yahoo Finance)
Feb-16-24 12:00PM	The Joy of Eating the Real Thing (The Wall Street Journal)
Feb-08-24 10:10AM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
Feb-06-24 04:30PM	McCormick & Company to Present at Consumer Analyst Group of New York Conference (PR Newswire)
Jan-25-24 03:36PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
06:55AM	McCormick & Company Issues FY24 Outlook (RTT News)
06:30AM	McCORMICK REPORTS 2023 FINANCIAL RESULTS AND PROVIDES 2024 OUTLOOK (PR Newswire)
Jan-23-24 04:20PM	McCormick Appoints Terry Thomas to Board of Directors (PR Newswire)
Jan-17-24 10:15AM	McCormick & Company Named to Corporate Knights Global 100 Sustainability Index for 8th Consecutive Year (PR Newswire)
Jan-03-24 08:00AM	McCormick & Company to Report 2023 Fourth Quarter Financial Results on January 25, 2024 (PR Newswire)
Dec-11-23 04:15PM	McCormick & Company's 2050 Net-Zero Target Validated by Science Based Targets Initiative (PR Newswire)
Nov-28-23 06:22PM	McCormick Announces Increase in Quarterly Dividend (PR Newswire)
Nov-13-23 11:46AM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
Oct-05-23 07:48PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
08:10AM	McCormick & Company, Incorporated (NYSE:MKC) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-03-23 02:00PM	Consumers Are Buying More Spices at a Timeand Cooking Through Them (The Wall Street Journal) -8.46%
12:24PM	McCormick Sees Demand Fall in China, and Shares Sink (Investopedia)
12:13PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
11:30AM	Heres Why Wall Street Spat Out McCormick's Stock Today (The Wall Street Journal)
11:07AM	Stocks to Watch Tuesday: Netflix, Alibaba, Point Biopharma, McCormick, Airbnb (The Wall Street Journal)
10:32AM	McCormicks Stock Is Falling After Its Latest Earnings (The Wall Street Journal)
06:30AM	McCORMICK REPORTS STRONG THIRD QUARTER PERFORMANCE (PR Newswire)
Oct-02-23 06:06PM	JOLTS data, FTX trial, Evergrande, Hunter Biden: What to watch (Yahoo Finance Video)
11:51AM	Earnings, September jobs report: What to watch this week (Yahoo Finance Video)
Sep-28-23 06:07PM	McCormick Declares $0.39 Quarterly Dividend (PR Newswire)
Sep-19-23 01:18PM	2 Undervalued Dividend Aristocrats for Growth and Income (GuruFocus.com)
07:20AM	Owens Corning and Labcorp have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Sep-06-23 08:00AM	McCormick & Company, Incorporated to Report 2023 Third Quarter Financial Results on October 3, 2023 (PR Newswire)
Aug-31-23 12:04PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
Aug-22-23 08:11PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research)
08:00AM	McCormick & Company to Participate in the Barclays Global Consumer Staples Conference (PR Newswire)
Jul-06-23 07:31AM	Daily Spotlight: GDP Forecast for 2Q23 is now 2.3% (Argus Research)
Jun-30-23 12:34PM	Analyst Report: McCormick & Co., Inc. (Argus Research)
12:19PM	Market Update: MKC, PAYX (Argus Research)
Jun-29-23 12:18PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research) -5.52%
10:14AM	McCormick stock dips despite earnings beat (Yahoo Finance Video)
06:30AM	McCORMICK REPORTS STRONG SECOND QUARTER PERFORMANCE AND RAISES 2023 PROFIT OUTLOOK (PR Newswire)
Jun-28-23 04:20PM	Brendan Foley promoted to McCormick Chief Executive Officer; Lawrence Kurzius to continue as Executive Chairman of the Board (PR Newswire)
Jun-27-23 04:40PM	McCormick Declares $0.39 Quarterly Dividend (PR Newswire)
Jun-08-23 01:30PM	McCormick Recognizes 2023 Unsung Heroes During In-Person Event at M&T Bank Stadium; Awards $105,000 in Total Scholarships (PR Newswire)
Jun-01-23 04:30PM	McCormick & Company, Incorporated to Report 2023 Second Quarter Financial Results on June 29, 2023 (PR Newswire)
08:00AM	McCormick Appoints Ana Sanchez, Andrew Foust, and Kasey Jenkins to the Company's Management Committee (PR Newswire)
May-22-23 08:00AM	McCormick & Company to Participate in the Deutsche Bank Global Consumer Conference (PR Newswire)
May-17-23 08:00AM	McCormick Announces Malcolm Swift's Plan to Retire (PR Newswire)
Apr-25-23 08:30AM	McCormick Releases 2022 Purpose-led Performance Progress Report Highlighting Positive Impact of Farmer Resiliency, Sustainable Sourcing and Climate Initiatives (PR Newswire)
Mar-30-23 01:05PM	Analyst Report: McCormick & Co., Inc. (Argus Research)
12:50PM	Market Update: GPS, IART, MKC (Argus Research)
Mar-29-23 04:20PM	McCormick Declares $0.39 Quarterly Dividend (PR Newswire)
Mar-28-23 07:52PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research) +9.61%
03:54PM	McCormick & Company stock jumps after earnings beat (Yahoo Finance Video)
06:30AM	McCORMICK REPORTS FIRST QUARTER PERFORMANCE AND REAFFIRMS 2023 OUTLOOK (PR Newswire)
Mar-09-23 08:00AM	McCormick & Company Named to Barron's 2023 100 Most Sustainable Companies List (PR Newswire)
Mar-01-23 04:05PM	McCormick & Company's 2023 First Quarter Results Conference Call to be Available on the Web (PR Newswire)
Feb-06-23 04:44PM	McCormick & Company to Present at Consumer Analyst Group of New York Conference (PR Newswire)
Jan-27-23 07:30AM	Analyst Report: McCormick & Co., Inc. (Argus Research)
07:15AM	Market Digest: FCX, FLEX, LVS, MKC, NSC, PKG, STX, T, TSLA, ELAN (Argus Research)
Jan-26-23 07:26PM	Analyst Report: McCormick & Company, Incorporated (Morningstar Research) -5.80%
09:55AM	McCormick misses on Q4 earnings, issues weaker-than-expected guidance (Yahoo Finance Video)
06:30AM	McCORMICK REPORTS 2022 FINANCIAL RESULTS AND PROVIDES 2023 OUTLOOK (PR Newswire)
Jan-18-23 09:10AM	McCormick & Company Ranked World's 22nd Most Sustainable Corporation and No. 1 in Food on the Corporate Knights 2023 Global 100 Sustainability Index (PR Newswire)
Jan-11-23 09:15AM	McCormick & Company Named One of America's Most JUST Companies by JUST Capital (PR Newswire)
Jan-03-23 08:00AM	McCormick & Company's 2022 Fourth Quarter Results Conference Call to be Available on the Web (PR Newswire)
Dec-16-22 09:05AM	B&G Foods' (BGS) Sale of Back to Nature to Enhance Structure (Zacks)
Dec-15-22 09:55AM	The J.M. Smucker (SJM) Pricing Actions & Coffee Business Solid (Zacks)
09:23AM	Lamb Weston (LW) Rewards Investors With a Dividend Raise (Zacks)
Dec-07-22 04:54PM	11 Best Low-Risk Dividend Stocks to Invest In (Insider Monkey)
Dec-06-22 07:15AM	McCormick's 'Flavor Forecast' predicts culinary trends of 2023 (American City Business Journals)
Dec-05-22 11:48AM	McCormick taps new chief human relations officer (American City Business Journals)
09:12AM	Sarah Piper Named Chief Human Relations Officer for McCormick (PR Newswire)
Dec-03-22 07:27AM	McCormick's (NYSE:MKC) Dividend Will Be Increased To $0.39 (Simply Wall St.)

McCormick & Co., Inc. engages in the manufacturing, marketing, and distribution of spices, seasoning mixes, condiments, and other flavorful products to retail outlets, food manufacturers, and foodservice businesses. It operates through the Consumer and Flavor Solutions segments. The Consumer segment sells spices, seasonings, condiments, and sauces. The Flavor Solutions segment includes seasoning blends, spices and herbs, condiments, coating systems, and compound flavors. The company was founded by Willoughby M. McCormick in 1889 and is headquartered in Baltimore, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jenkins Katherine	Chief Growth Officer	Apr 22 '24	Sale	74.35	1,726	128,326	0	Apr 23 05:15 PM
LITTLE PATRICIA A	Director	Apr 01 '24	Option Exercise	44.05	20,000	881,050	34,732	Apr 02 01:18 PM
LITTLE PATRICIA A	Director	Apr 01 '24	Sale	75.57	20,000	1,511,445	24,732	Apr 02 01:18 PM
Montiel Maritza Gomez	Director	Mar 28 '24	Option Exercise	49.96	7,000	349,720	12,594	Mar 29 12:12 PM
Montiel Maritza Gomez	Director	Mar 28 '24	Sale	77.00	7,000	538,986	5,594	Mar 29 12:12 PM
PRESTON MARGARET M V	Director	Mar 15 '24	Option Exercise	0.00	1,255	0	98,864	Mar 19 03:49 PM
BRAMMAN ANNE L	Director	Mar 15 '24	Option Exercise	0.00	1,255	0	5,239	Mar 19 03:39 PM
HRABOWSKI FREEMAN A III	Director	Mar 15 '24	Option Exercise	0.00	1,255	0	102,456	Mar 19 02:56 PM
Montiel Maritza Gomez	Director	Mar 15 '24	Option Exercise	0.00	1,255	0	5,594	Mar 19 02:54 PM
LITTLE PATRICIA A	Director	Mar 15 '24	Option Exercise	0.00	1,255	0	24,732	Mar 19 02:52 PM
Jenkins Katherine	Chief Growth Officer	Mar 15 '24	Option Exercise	0.00	802	0	3,383	Mar 19 02:28 PM
Foust Andrew	President, Americas	Mar 15 '24	Option Exercise	0.00	1,239	0	5,406	Mar 19 02:25 PM
Piper Sarah	Chief Human Relations Officer	Mar 15 '24	Option Exercise	0.00	367	0	2,177	Mar 19 02:22 PM
Sanchez Ana	President EMEA	Mar 15 '24	Option Exercise	0.00	801	0	3,818	Mar 19 02:20 PM
MANGAN MICHAEL D	Director	Feb 15 '24	Option Exercise	35.55	5,000	177,750	44,181	Feb 20 11:08 AM
MANGAN MICHAEL D	Director	Feb 15 '24	Sale	65.20	5,000	325,996	39,181	Feb 20 11:08 AM
HRABOWSKI FREEMAN A III	Director	Feb 06 '24	Option Exercise	35.55	10,000	355,500	106,538	Feb 08 08:36 AM
PRESTON MARGARET M V	Director	Jan 30 '24	Option Exercise	35.55	10,000	355,500	102,261	Jan 31 03:09 PM
Tapiero Jacques	Director	Jan 23 '24	Option Exercise	66.80	3	188	26,500	Jan 25 12:43 PM
Tapiero Jacques	Director	Jan 02 '24	Option Exercise	69.54	451	31,373	26,336	Jan 03 03:08 PM
Schwartz Jeffery D	Vice President, Gen Counsel	Oct 25 '23	Sale	64.37	2,000	128,738	55,174	Oct 27 11:11 AM
MANGAN MICHAEL D	Director	Aug 21 '23	Option Exercise	35.50	5,000	177,500	44,181	Aug 22 03:59 PM
MANGAN MICHAEL D	Director	Aug 21 '23	Sale	83.63	5,000	418,142	39,181	Aug 22 03:59 PM
Schwartz Jeffery D	Vice President, Gen Counsel	Jul 28 '23	Option Exercise	49.02	2,600	127,465	63,374	Jul 31 11:13 AM
Schwartz Jeffery D	Vice President, Gen Counsel	Jul 28 '23	Sale	90.02	2,600	234,046	60,774	Jul 31 11:13 AM
Tapiero Jacques	Director	Jul 26 '23	Option Exercise	35.55	5,000	177,750	30,612	Jul 27 01:40 PM
Tapiero Jacques	Director	Jul 26 '23	Sale	89.88	5,000	449,422	25,612	Jul 27 01:40 PM
Schwartz Jeffery D	Vice President, Gen Counsel	Jul 21 '23	Option Exercise	49.02	3,600	176,490	60,774	Jul 24 11:46 AM
Schwartz Jeffery D	Vice President, Gen Counsel	Jul 21 '23	Sale	87.48	3,600	314,919	57,174	Jul 24 11:46 AM
Kurzius Lawrence Erik	Chairman & CEO	May 12 '23	Option Exercise	38.15	39,906	1,522,214	199,485	May 16 01:58 PM
Kurzius Lawrence Erik	Chairman & CEO	May 12 '23	Sale	90.02	39,906	3,592,378	159,579	May 16 01:58 PM

Open in Screener

NVCR

NovoCure Ltd

May 03 • 04:00PM ET

14.78

Dollar change +0.59
Percentage change 4.16	%

Healthcare • Medical Devices • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB VXF VBK IBB IHI SCHA IWP VHT IWF

Index	-	P/E	-	EPS (ttm)	-1.81	Insider Own	10.09%	Shs Outstand	107.08M	Perf Week	16.98%
Market Cap	1.59B	Forward P/E	-	EPS next Y	-1.76	Insider Trans	-0.10%	Shs Float	96.75M	Perf Month	3.43%
Income	-192.74M	PEG	-	EPS next Q	-0.41	Inst Own	81.17%	Short Float	6.24%	Perf Quarter	4.82%
Sales	525.66M	P/S	3.03	EPS this Y	15.90%	Inst Trans	2.95%	Short Ratio	4.66	Perf Half Y	12.82%
Book/sh	3.34	P/B	4.43	EPS next Y	-7.23%	ROA	-16.79%	Short Interest	6.04M	Perf Year	-77.59%
Cash/sh	8.12	P/C	1.82	EPS next 5Y	-	ROE	-48.70%	52W Range	10.87 - 83.60	Perf YTD	-1.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-22.97%	ROI	-20.19%	52W High	-82.32%	Beta	0.60
Dividend TTM	-	Quick Ratio	5.99	Sales past 5Y	17.16%	Gross Margin	74.97%	52W Low	35.97%	ATR (14)	0.84
Dividend Ex-Date	-	Current Ratio	6.26	EPS Y/Y TTM	-34.69%	Oper. Margin	-39.07%	RSI (14)	61.74	Volatility	7.83% 5.79%
Employees	1453	Debt/Eq	1.66	Sales Y/Y TTM	0.61%	Profit Margin	-36.67%	Recom	2.14	Target Price	25.50
Option/Short	Yes / Yes	LT Debt/Eq	1.66	EPS Q/Q	28.06%	Payout	-	Rel Volume	0.88	Prev Close	14.19
Sales Surprise	5.37%	EPS Surprise	14.29%	Sales Q/Q	13.36%	Earnings	May 02 BMO	Avg Volume	1.30M	Price	14.78
SMA20	13.89%	SMA50	4.09%	SMA200	-13.73%	Trades		Volume	1,145,695	Change	4.16%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Resumed	JP Morgan	Neutral	$15
Aug-28-23	Downgrade	H.C. Wainwright	Buy → Neutral	$85 → $25
Aug-08-23	Upgrade	Piper Sandler	Neutral → Overweight	$45
Aug-04-23	Initiated	SVB Securities	Outperform	$51
Jul-31-23	Upgrade	Evercore ISI	Underperform → In-line	$33
Jun-07-23	Upgrade	Wedbush	Underperform → Neutral	$53 → $46
May-16-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$70 → $104
Mar-17-23	Downgrade	JP Morgan	Neutral → Underweight	$99 → $50
Jan-06-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$89 → $107
Jan-05-23	Reiterated	H.C. Wainwright	Buy	$100 → $140
Nov-29-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$74 → $89
Oct-24-22	Downgrade	Piper Sandler	Overweight → Neutral	$90 → $70
Jul-05-22	Downgrade	Evercore ISI	In-line → Underperform
May-16-22	Initiated	H.C. Wainwright	Buy	$115
Feb-08-22	Initiated	Loop Capital	Buy	$200
Feb-02-22	Upgrade	Oppenheimer	Perform → Outperform	$98
Jan-20-22	Upgrade	Truist	Hold → Buy	$125
Jan-03-22	Upgrade	Evercore ISI	Underperform → In-line	$82
Jul-01-21	Downgrade	Mizuho	Buy → Neutral
Apr-14-21	Downgrade	Wedbush	Neutral → Underperform	$159 → $154

Show Previous Ratings

May-03-24 12:08PM	NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:00AM	NovoCure (NVCR) Q1 2024 Earnings Call Transcript (Motley Fool)
May-02-24 01:19PM	NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue (MT Newswires) +11.38%
11:56AM	NVCR Stock Earnings: NovoCure Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:45AM	NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported (GuruFocus.com)
08:25AM	Loading…
08:25AM	NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:28AM	NovoCure: Q1 Earnings Snapshot (Associated Press Finance)
07:01AM	Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon (Business Wire)
07:00AM	Novocure Reports First Quarter 2024 Financial Results (Business Wire)
Apr-25-24 10:01AM	NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-24-24 10:45AM	Results of Novocure's METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024 (Business Wire)
Apr-05-24 07:00AM	Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024 (Business Wire)
Apr-04-24 11:33AM	Aggressive Stock Portfolio: 13 Stocks Picked by Analysts (Insider Monkey)
Apr-01-24 12:00PM	NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade (Zacks)
07:00AM	Novocure to Report First Quarter 2024 Financial Results (Business Wire)
06:34AM	Loading…
Mar-30-24 06:34AM	Why NovoCure Stock Soared 18.3% This Week (Motley Fool)
Mar-28-24 11:50AM	Why Novocure Stock Is Jumping Today (Motley Fool) +6.76%
05:01AM	NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock? (Zacks)
Mar-27-24 04:08PM	Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish (Investor's Business Daily) +12.01%
09:29AM	Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer (Business Wire)
09:16AM	Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment (Investor's Business Daily)
07:14AM	UPDATE 1-Novocure's lung cancer therapy succeeds in late-stage trial (Reuters)
07:12AM	Novocure's device shown to slow cancer progression in the brain in trial (Reuters)
07:05AM	Novocure's lung cancer therapy succeeds in late-stage trial (Reuters)
07:00AM	METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer (Business Wire)
Mar-13-24 09:55AM	Does NovoCure (NVCR) Have the Potential to Rally 63.51% as Wall Street Analysts Expect? (Zacks)
Mar-11-24 07:00AM	INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO (Business Wire)
Feb-23-24 11:43AM	NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 12:15PM	NovoCure (NVCR) Q4 2023 Earnings Call Transcript (Motley Fool)
08:25AM	NovoCure (NVCR) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:36AM	Loading…
07:36AM	NovoCure Ltd (NVCR) Reports Mixed Financial Results for Q4 and Full Year 2023 (GuruFocus.com)
07:23AM	NovoCure: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update (Business Wire)
Jan-19-24 07:46AM	Strength Seen in NovoCure (NVCR): Can Its 16.8% Jump Turn into More Strength? (Zacks)
Jan-18-24 02:19PM	Why Is Cancer Focused Novocure Stock Trading Higher Today? (Benzinga) +16.75%
07:00AM	Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer (Business Wire)
Jan-11-24 09:55AM	Wall Street Analysts Predict a 105.85% Upside in NovoCure (NVCR): Here's What You Should Know (Zacks)
Jan-09-24 07:00AM	Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma (Business Wire)
Jan-08-24 07:00AM	Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update (Business Wire) +11.61%
Jan-04-24 04:05PM	Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer (Business Wire)
Dec-27-23 07:00AM	Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference (Business Wire) +12.20%
Dec-08-23 04:09AM	15 Best Falling Stocks To Buy Now (Insider Monkey)
Dec-04-23 04:46PM	The Top and Bottom Stocks of 2023 (Investopedia)
Nov-28-23 10:51AM	Novocure Layoffs 2023: What to Know About the Latest NVCR Job Cuts (InvestorPlace)
07:30AM	Novocure Announces Portfolio Prioritization and Strategic Restructuring Plan Focused on Near-term Growth Drivers and an Accelerated Path to Profitability (Business Wire)
Nov-21-23 07:00AM	Novocure to Participate in 35th Annual Piper Sandler Healthcare Conference (Business Wire)
Nov-14-23 09:09AM	11 Best Undervalued UK Stocks To Buy Now (Insider Monkey) +12.48%
Nov-10-23 08:00AM	Novocure Announces Presentations on Tumor Treating Fields Therapy, Including New Clinical Data and Real-World Evidence, at 2023 Society for Neuro-Oncology Annual Meeting (Business Wire)
Nov-03-23 06:45AM	Is Novocure Stock a Buy? (Motley Fool)
Oct-30-23 02:04AM	The NovoCure Ltd (NVCR) Company: A Short SWOT Analysis (GuruFocus.com)
Oct-28-23 08:39AM	NovoCure Limited (NASDAQ:NVCR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 04:35PM	Why Novocure Stock Was Sick Today (Motley Fool) -7.53%
11:00AM	NovoCure (NVCR) Q3 2023 Earnings Call Transcript (Motley Fool)
08:52AM	NovoCure Ltd (NVCR) Reports Q3 2023 Financial Results (GuruFocus.com)
08:30AM	NovoCure (NVCR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:24AM	NovoCure: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Novocure Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-15-23 06:05PM	Novocure Announces Presence at European Society for Medical Oncology (ESMO) Congress 2023 (Business Wire)
Oct-12-23 08:00AM	Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program (Business Wire) -5.53%
Oct-02-23 07:00AM	Novocure to Report Third Quarter 2023 Financial Results (Business Wire)
Sep-29-23 05:00PM	Novocure Announces Presence at American Society for Radiation Oncology (ASTRO) 2023 Annual Meeting (Business Wire)
Sep-18-23 11:47AM	Should You Hold NovoCure Limited (NVCR)? (Insider Monkey)
Sep-08-23 04:01PM	Novocure Highlights Use of Tumor Treating Fields Therapy in Treatment of Non-Small Cell Lung Cancer at 2023 World Conference on Lung Cancer (Business Wire)
Sep-06-23 02:27PM	3 Healthcare Stocks to Sell in September Before They Crash & Burn (InvestorPlace)
Sep-04-23 09:30AM	Down 31% in 1 Day, What's Next for NovoCure Stock? (Motley Fool)
Aug-31-23 06:52PM	Why Novocure Stock Fell 24.4% This Week (Motley Fool)
09:55AM	Is NovoCure's Stock Headed for a Free Fall? (Motley Fool)
Aug-29-23 06:31PM	Novocure Announces The Lancet Oncology Publishes Primary Data from Phase 3 LUNAR Clinical Trial in Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies (Business Wire) +8.84%
Aug-28-23 05:15PM	Novocure Shares Plunge After Its Ovarian Cancer Treatment Fails to Meet Goal (Investopedia) -37.50%
04:08PM	Novocure Plummets 38% After Its Treatment For Ovarian Cancer Fails (Investor's Business Daily)
02:19PM	Novocure Plummets 35% After Its Cancer Treatment Fails In Ovarian Cancer (Investor's Business Daily)
12:21PM	Why NovoCure Stock Is Crashing Today (Motley Fool)
12:16PM	3M, Boston Scientific rise; Abcam, NovoCure fall, Monday, 8/28/2023 (AP Finance)
12:10PM	NovoCure Ltd (NVCR): A Deep Dive into Its Performance Potential (GuruFocus.com)
11:47AM	NovoCure (NVCR): A Smart Investment or a Value Trap? An In-Depth Exploration (GuruFocus.com)
09:34AM	Midday movers: 3M, XPeng, Hawaiian Electric Industries and more (Investing.com)
07:27AM	UPDATE 1-Novocure's cancer therapy fails to meet main goal in late-stage trial (Reuters)
07:10AM	Novocure says its ovarian cancer therapy did not meet main goal in late-stage trial (Reuters)
07:00AM	Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer (Business Wire)
Aug-25-23 08:20AM	Could NovoCure Stock Help You Become a Millionaire? (Motley Fool)
07:00AM	Novocure to Participate in Upcoming Investor Conferences (Business Wire)
Aug-15-23 09:30AM	Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod (Zacks)
Aug-13-23 05:49PM	15 Worst Performing Healthcare Stocks in 2023 (Insider Monkey)
Aug-09-23 10:45AM	2 Incredibly Cheap Growth Stocks to Buy in August (Motley Fool) +7.13%
05:10AM	Is NovoCure Stock a Buy Now? (Motley Fool)
Aug-08-23 04:11PM	Why Novocure Was a Healthy Stock Today (Motley Fool)
10:02AM	DraftKings upgraded, Home Depot downgraded: Wall Street's top analyst calls (The Fly)
Aug-04-23 09:38AM	Apple downgraded, Amazon upgraded: Wall Street's top analyst calls (The Fly)
Aug-01-23 03:54PM	10 Oversold NASDAQ Stocks to Buy (Insider Monkey)
Jul-27-23 06:56PM	Why Novocure Stock Tumbled by Nearly 16% Today (Motley Fool) -15.89%
11:30AM	NovoCure (NVCR) Q2 2023 Earnings Call Transcript (Motley Fool)
08:15AM	NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:07AM	NovoCure: Q2 Earnings Snapshot (AP Finance)
07:00AM	Novocure Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-25-23 10:01AM	Earnings Preview: Revvity (RVTY) Q2 Earnings Expected to Decline (Zacks)
Jul-21-23 08:00AM	Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic Cancer (Business Wire)
Jul-06-23 01:17PM	Here's Why Novocure Stock Dropped 42% in June (Motley Fool)
Jul-03-23 08:00AM	Novocure to Report Second Quarter 2023 Financial Results (Business Wire)
Jun-12-23 09:30AM	3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon (InvestorPlace)
05:39AM	This Beaten-Down Growth Stock Has 99% Upside, According to Wall Street (Motley Fool)

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GROENHUYSEN WILHELMUS CM	Chief Operating Officer	Mar 04 '24	Sale	16.01	1,217	19,484	251,235	Mar 05 04:09 PM
Leonard Frank X	EVP, Pres., Novocure Oncology	Mar 04 '24	Sale	16.01	840	13,448	160,098	Mar 05 04:08 PM
GROENHUYSEN WILHELMUS CM	Chief Operating Officer	Mar 01 '24	Sale	16.03	2,107	33,769	252,452	Mar 05 04:09 PM
Leonard Frank X	EVP, Pres., Novocure Oncology	Mar 01 '24	Sale	16.03	1,679	26,909	160,938	Mar 05 04:08 PM
GROENHUYSEN WILHELMUS CM	Chief Operating Officer	Feb 28 '24	Sale	16.14	2,303	37,177	254,559	Feb 29 04:28 PM
Leonard Frank X	EVP, Pres., Novocure Oncology	Feb 28 '24	Sale	16.14	2,078	33,545	162,617	Feb 29 04:38 PM
Shah Pritesh	Chief Growth Officer	Nov 07 '23	Sale	12.65	382	4,832	124,511	Nov 08 04:22 PM
Cordova Ashley	Chief Financial Officer	Nov 02 '23	Option Exercise	11.46	175	2,006	117,618	Nov 02 04:20 PM
Cordova Ashley	Chief Financial Officer	Oct 31 '23	Option Exercise	9.58	17,793	170,447	117,443	Nov 02 04:20 PM
Cordova Ashley	Chief Financial Officer	Sep 01 '23	Sale	21.82	883	19,265	99,650	Sep 05 04:24 PM
GROENHUYSEN WILHELMUS CM	Chief Operating Officer	Sep 01 '23	Sale	21.82	294	6,414	209,825	Sep 05 04:24 PM
Shah Pritesh	Chief Growth Officer	Sep 01 '23	Sale	21.82	273	5,956	124,893	Sep 05 04:23 PM
Cordova Ashley	Chief Financial Officer	Aug 02 '23	Sale	30.25	1,144	34,607	100,533	Aug 04 04:02 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

MKC

McCormick & Co., Inc.

NVCR

NovoCure Ltd

Upgrade your FINVIZ experience